Abstract The known complex trans-[Pt2I2(μ-I)2(dmso)2], 1, was reacted with 2 or 4 equiv of 1-methylimidazole and 4-methylpyridine as two different N-heterocycle ligands. The symmetrical cleavage of this di-nuclear structure by 2… Click to show full abstract
Abstract The known complex trans-[Pt2I2(μ-I)2(dmso)2], 1, was reacted with 2 or 4 equiv of 1-methylimidazole and 4-methylpyridine as two different N-heterocycle ligands. The symmetrical cleavage of this di-nuclear structure by 2 and 4 equiv of 1-methylimidazole led to formation of the complexes trans-[PtI2(1-MeIm)(dmso)], 2, and trans-[PtI2(1-MeIm)2], 4, respectively. In the case of 4-methylpyridine, the reaction of 1 with both 2 and 4 equiv of the ligand ended up to the complex trans-[PtI2(4-MePy)(dmso)], 3. Also, the reactivity of the complexes 2 and 4 was investigated toward some common diphosphine ligands. The complexes 5, 6 and 7 with general formula of [PtI2(P^P)] were formed when the complexes 2 and 4 were reacted with dppm, dppe and dppp ligands respectively while the dinuclear complexes 8 and 11 with bridging diphosphine were formed using the linear dppac ligand. The complexes were fully characterized using the multinuclear (1H and 31P{H}) NMR spectroscopy and elemental analysis. The structure of typical complex 2 was further determined by X-ray crystallography. Also, DFT calculations were performed in order to gain the optimized structures and further insight into the nature of the absorption characters of the new complexes.
               
Click one of the above tabs to view related content.